Treatment of OCD Symptoms in Schizophrenia

Pharmacological Treatment

Alternative SSRIs can be used at OCD-specific doses: fluoxetine 60-80 mg/day or paroxetine 60 mg/day, according to the Nature Reviews Disease Primers 1
Allow 8-12 weeks at maximum tolerated dose before declaring treatment failure, as recommended by the Nature Reviews Disease Primers 1
Monitor for serotonin syndrome when combining SSRIs with antipsychotics, as advised by Praxis Medical Insights 2
Risperidone and aripiprazole have the strongest evidence for SSRI-resistant OCD, with approximately one-third of patients showing clinically meaningful response, according to Praxis Medical Insights 2
Monitor metabolic parameters, such as weight, glucose, and lipids, when using antipsychotics for augmentation, as recommended by Praxis Medical Insights 2
N-acetylcysteine has the strongest evidence among glutamatergic agents, with 3 out of 5 RCTs showing superiority to placebo, according to Praxis Medical Insights 2
Memantine has demonstrated efficacy in several trials, as reported by Praxis Medical Insights 2
Consider clomipramine if multiple SSRIs have failed, though use with extreme caution given cardiac risks and drug interactions, as advised by the Nature Reviews Disease Primers 1

CBT with exposure and response prevention should be added regardless of pharmacological approach, as it shows larger effect sizes than antipsychotic augmentation, according to Praxis Medical Insights 2
Deliver 10-20 sessions in-person or via internet-based protocols, as recommended by the Nature Reviews Disease Primers 1
Patient adherence to between-session homework, such as ERP exercises at home, is the most robust predictor of good outcome, as reported by the Nature Reviews Disease Primers 1
Consider intensive CBT protocols, such as multiple sessions over days, for severe cases, as advised by the Nature Reviews Disease Primers 1

Continue treatment for a minimum of 12-24 months after achieving remission due to high relapse rates after discontinuation, as recommended by the Nature Reviews Disease Primers and Praxis Medical Insights 1, 2
Monthly booster CBT sessions for 3-6 months after acute response, as advised by Praxis Medical Insights 3
Screen for metabolic side effects if using antipsychotic augmentation, as recommended by Praxis Medical Insights 2
Watch for emergence of serotonin syndrome when combining serotonergic agents, as advised by Praxis Medical Insights 2

Never discontinue the antipsychotic to treat OCS, as this will lead to psychotic relapse, as warned by the American Journal of Psychiatry 4
Full therapeutic effect may be delayed until 5 weeks or longer, with maximal improvement by week 12, as reported by Praxis Medical Insights 5
Early treatment changes prevent adequate assessment of efficacy, as advised by the Nature Reviews Disease Primers 1

Deep repetitive transcranial magnetic stimulation (rTMS) is FDA-approved for treatment-resistant OCD with moderate effect size and 3-fold increased likelihood of response versus sham, as reported by Praxis Medical Insights 2
Consider transcranial direct current stimulation (tDCS) or deep brain stimulation (DBS) for severe, highly treatment-resistant cases, as advised by Praxis Medical Insights 2
Refer to intensive outpatient or residential OCD treatment programs when standard approaches fail, as recommended by Praxis Medical Insights 2, 3